39 results on '"Duncan, Kelly"'
Search Results
2. Data from Intrinsic Resistance to MEK Inhibition through BET Protein–Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer
3. Data from Intrinsic Resistance to MEK Inhibition through BET Protein–Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer
4. Supplemental Figures and Legends 1 - 6 from Intrinsic Resistance to MEK Inhibition through BET Protein–Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer
5. Supplementary Materials and Methods from A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
6. Table S1 from A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
7. Data from A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
8. Table S1 from A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
9. Data from A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
10. Supplementary Materials and Methods from A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
11. Supplementary Table 3 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
12. Supplementary Table 9 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
13. Supplementary Tables 10-15 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
14. Supplementary Tables 10-15 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
15. Supplementary Table 1 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
16. Supplementary Table 2 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
17. Supplementary Table 1 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
18. Supplementary Table 9 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
19. Data from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
20. Supplementary Table 8 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
21. Supplementary Figures 1-4 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
22. Supplementary Table 6 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
23. Supplementary Table 6 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
24. Supplementary Table 7 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
25. Supplementary Table 3 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
26. Supplementary Table 2 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
27. Supplementary Table 5 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
28. Supplementary Table 4 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
29. Supplementary Table 5 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
30. Supplementary Methods, Figure Legends 1-4, Table Legends 1-15 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
31. Supplementary Table 7 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
32. Supplementary Table 4 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
33. Supplementary Figures 1-4 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
34. Supplementary Methods, Figure Legends 1-4, Table Legends 1-15 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
35. Supplementary Table 8 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
36. Intrinsic Resistance to MEK Inhibition through BET Protein–Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer
37. A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
38. Abstract A8: Androgen regulation of SRF target genes in prostate cancer cells is mediated in part by the small GTPase RhoA
39. Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.